| |
Home »
Articles » Pharmaceutical Industry issues
Industry issues - Medical / Pharmaceutical Sales industry
articles
Health
Technology Assessment International 2004
(Published 27 January
2005)
Since we reported on the 2002 annual conference of the
International Society for Technology Assessment in Health Care (ISTAHC), the
organisation has metamorphosed into Health Technology Assessment international
(HTAi) - a new organisation with a new Board and one now very much more
interested in including the industry as a major stakeholder. HTAi's mission is
'to support the development, communication, understanding and use of HTA
globally as a scientifically based means of promoting the introduction of
effective innovation and the effective use of resources in health care'. [read
article]
See below for further Pharmaceutical Industry
articles or review other
Pharmaceutical
Industry titles.
What Most Clinicians Say They
Want
(Date published: 05 March 2004)
In Stephen Spielberg's
recent movie, "The Minority Report," we are introduced to a future vision of
the power of humanity and technology. One interesting aspect of the movie, at
least for us "gadget freaks," was the method used by advertisers to target
their message to the individual. Tom Cruise's character is seen walking through
shopping malls as the individual stores and 3D advertisements call out to him
by name and pitch their products. Though this movie was futuristic, the idea of
using information to target your message and win competitive advantage is far
from new. [read
article]
In Defence of the
Realm
(Date published: 20 January 2004)
Following shortly after
Channel 4's rather inflammatory documentary Dying for Drugs, the BMJ at the end
of May ran a wholly negative 'theme' issue on the Industry, essentially saying
what 'naughty boys' companies were. According to the BMJ, doctors and drug
companies are 'entwined in an embrace of avarice and excess, which is
distorting medical information and patient care.' These comments were
accompanied by a whole series of articles looking at the 'entangled'
relationships between the Industry and doctors, as well as the way the industry
reports its clinical trial results. It was all there - the use of third parties
by companies to 'spin' their messages, the 'abuse' of patient organisations,
industry funding corrupting medical journals, 'conference tourism,' bribery,
bias in clinical trials, undue pressure on GPs, etc, etc..... The key issue of
course is always what should companies do in response to this kind of stuff.
[read
article]
Deconstructed
Genes
(Date published: 26 February 2004)
Advances in genetics and
genomics still continue to receive a very high press profile. The reasons are
not hard to find. 2003 marked the fiftieth anniversary of Crick and Watson's
ground-breaking discovery of the structure of DNA and it was also the year in
which the sequencing of the human genome - the blueprint of life - was finally
completed. The complete map of our chromosomes was elucidated for the first
time. [read
article]
Aquisitions: the
benefits and risks
(Date published: 01 January 2004)
Over recent
years both in Healthcare and other industries, there has been considerable
change in ownership of the businesses that we work for. These acquisitions seem
set to continue, an article in last weeks Financial Times reported a large
increase in Mergers and Acquisitions activity at the end of 2003 and expect
this to accelerate in 2004. Not too many years ago there were many smaller
organisations in Healthcare, but over the years many of the successful
businesses have been acquired and some of the less successful businesses
disappeared from the competitive landscape altogether. This very magazine
underlines the fact that change is the only constant in business, with
acquisition announcements almost every issue. [read
article]
e-Detailing :
revolutionizing professional healthcare marketing
(Date published: 18
September 2002)
It has been an interesting journey for e-detailing;
something that has for a while now been hyped as the 'killer' e-business
application for today's pharmaceutical sales & marketing teams with which
to interact with their direct customer base - the healthcare profession. After
a lot of dipping of toes into the e-detailing water by the industry with
somewhat muted success to date, it is only now that models are beginning to
emerge that look set to fulfill the initial hope and promise. [read
article]
Navigating the
eDetailing Maze
(Date published: 05 July 2002)
eDetailing is
currently under consideration by many pharmaceutical companies as a way to
maximise sales force time, cut costs and increase physician prescribing.
eDetailing is not a single entity but can take many different forms: from
remote live discussion with a sales rep to a purely scripted interaction with a
web site or an Interactive Voice Response phone line. Most eDetailing models
have been tried in the US and only some models such as some forms of Scripted
eDetailing have been shown by independent studies to increase prescribing
compared to traditional detailing methods. eDetail models from the US are
starting to become available in Europe where there are tighter regulations
concerning physician promotions that make it harder to incentivise physicians
to participate in eDetailing. [read
article]
e-Detailing Moves Into
Mainstream
(Published: 05 July 2002)
Faced with spiralling
marketing costs, reduced product lifecycles, and an increasing reliance on
"blockbuster" drug launches, pharmaceutical companies are turning to Internet
technologies to help them more effectively market and sell their products and
develop new channels to an increasingly complex customer base. [read
article]
Salesforce
Business Planning in the year 2000 and beyond
(Date published: 29
November 2001)
"Failure to plan is a plan to fail". Today, this maxim is
more apposite than ever. When in 1983 I started my career as a Medical
Representative with a large American pharmaceutical company, resources were
plentiful. Apparently, large share of voice automatically implied success which
was ostensibly measured in sales and volume turnover. Profit and Return on
Investment were almost incidental, left to the accountants who it seemed to me
presented such 'secrets' to board members in a large, darkened room on the top
floor of a tall building.[read
article]
Disclaimer
Net Media Marketing
excludes any warranty, express or implied, as to the quality, accuracy,
timeliness, completeness or fitness for a particular purpose of this briefing.
Net Media Marketing will not be liable for any claims, penalties, losses,
damages, costs, or expenses arising from the use of or inability to use this
briefing or from any unauthorised access to or alteration of the Briefing. Net
Media Marketing makes no warranty that the contents of this briefing are
compatible with all computer systems and browsers.
Pharmaceutical jobs, All
jobs & Vacancies, Pharmaceutical sales jobs,
Healthcare sales jobs,
Laboratory sales jobs,
Veterinary sales jobs,
Dental sales jobs,
Trainee
medical sales jobs, Nurse Advisor
jobs, Sales Management
jobs, Marketing
jobs, Senior Management
jobs, Regulatory &
Clinical jobs, Scientific Sales
Jobs, purchase British National Formulary
(BNF)
|
